Presyo ng Stock at Balita sa Guardant Health Inc (GH)

Kita sa Q3 2026 • Na-release • Nalampasan ang EPS +7.77% • Mas mataas ang kita +2.95%

Tingnan ang mga resulta

GH:NASDAQ

Guardant Health Inc

$150.87

-1.67%

(-2.56) 1D

$149.89

-0.65% (-0.98)

Pagkalipas ng oras ng trabaho

Sarado: Nob 6, 4:00:01 PM GMT-5 · USD

Lahat ng simbolo

	Simbolo	Presyo	Palitan	% ng Pagbabago

Bumubuo ng mga nangungunang insight para sa GH...

Buksan

$141.83

Mataas

$152.60

Mababa

$136.42

Mkt. cap

20.25B

Avg. na dami

1.86M

Dami

4.70M

Mataas nang 52-wk

$191.01

Mababa nang 52-wk

$74.55

EPS

-$3.50

Beta

1.67

Mga natitirang share

134.20M

Bilang ng mga empleyado

Buksan

$141.83

Mataas

$152.60

Mababa

$136.42

Mkt. cap

20.25B

Avg. na dami

1.86M

Dami

4.70M

Mataas nang 52-wk

$191.01

Mababa nang 52-wk

$74.55

EPS

-$3.50

Beta

1.67

Mga natitirang share

134.20M

Bilang ng mga empleyado

Mga kaugnay na stock

Twist Bioscience Corp

$120.79

+0.15%

Mga balita at kwento

Mula sa mga source sa web at partner sa balita

GuruFocus

3 oras ang nakalipas

Guardant Health Stocks Fall 9.49% as Cash Burn Outlook Rises Des

Investor's Business Daily

6 oras ang nakalipas

Blood-Testing Gore Continues As Natera, Guardant Report

Investing.com

9 oras ang nakalipas

Guardant Health stock reiterated at Buy by BTIG after Q3 beat

Investing.com

11 oras ang nakalipas

Why is Guardant Health stock sliding today?

Profile

Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia

Tungkol sa Guardant Health Inc

CEOHelmy Eltoukhy | AmirAli Talasaz

Mga Empleyado2.5K

Itinatag2012

HeadquartersPalo Alto, California, Estados Unidos

SektorHealth Care

IndustriyaHealth care provider

Websiteguardanthealth.com

Mga rating ng analyst

Batay sa 18 (na) analyst na nagbigay ng mga rating ng stock sa GH sa nakalipas na 3 buwan

Strong buy

Pagbili

Pag-hold

Pagbebenta

12 buwang forecas

Batay sa 18 (na) analyst sa Wall Street na nag-aalok ng mga target na presyo sa loob ng 12 buwan para sa GH sa nakalipas na 3 buwan.

Pinakamataas

Kasalukuyan $150.87

$225.00 (+49.14%)

Average

$205.44 (+36.17%)

Pinakamababa

$193.00 (+27.92%)

Analyst	Rekomendasyon	Aksyon	Target na presyo	Inaasahan	Petsa
Evie Koslosky Goldman Sachs	Buy	Maintained	$210.00	+39.2%	11/06/2026
Kyle Mikson CFA Canaccord Genuity	Buy	Reiterated	$205.00	+35.9%	11/06/2026
David Westenberg Piper Sandler	Buy	Maintained	$193.00	+27.9%	11/06/2026
Dan Leonard RBC Capital	Buy	Maintained	$200.00	+32.6%	11/06/2026
Daniel Brennan TD Cowen	Buy	Maintained	$220.00	+45.8%	11/06/2026
Catherine Ramsey Schulte Robert W. Baird	Buy	Maintained	$196.00	+29.9%	11/06/2026
Luke Sergott Barclays	Buy	Maintained	$220.00	+45.8%	11/06/2026
Daniel Arias Stifel Nicolaus	Buy	Maintained	$180.00	+19.3%	11/06/2026
Mark Massaro BTIG	Buy	Maintained	$210.00	+39.2%	10/27/2026
Max Masucci Roth MKM	Buy	Initiated	$200.00	+32.6%	10/22/2026
Kallum Titchmarsh Morgan Stanley	Buy	Maintained	$200.00	+32.6%	10/20/2026
Eve Burstein Bernstein	Buy	Reiterated	$210.00	+39.2%	10/19/2026
Casey Woodring J.P. Morgan	Buy	Maintained	$195.00	+29.3%	10/14/2026
Lu Li Bank of America Securities	Buy	Maintained	$200.00	+32.6%	10/09/2026
Michael Ryskin Bank of America Securities	Buy	Maintained	$200.00	+32.6%	10/09/2026
Subbu Nambi Guggenheim	Buy	Maintained	$200.00	+32.6%	10/01/2026
William Bonello Craig-Hallum	Buy	Maintained	-	-	09/15/2026
Unknown Analyst UBS	Buy	Maintained	$225.00	+49.1%	09/09/2026
Doug Schenkel UBS	Buy	Maintained	$225.00	+49.1%	09/09/2026
Jamie Clark Rothschild & Co Redburn	Buy	Initiated	$203.00	+34.6%	09/08/2026
Matt Larew William Blair	Buy	Maintained	-	-	09/08/2026
Bradley Bowers Mizuho Securities	Buy	Maintained	$200.00	+32.6%	08/04/2026
Mason Carrico Stephens	Buy	Maintained	$195.00	+29.3%	08/04/2026
Brandon Couillard Wells Fargo	Buy	Maintained	$125.00	-17.1%	07/29/2026
Patrick B Donnelly Citi	Buy	Maintained	$215.00	+42.5%	07/08/2026
Vijay Kumar Evercore ISI	Buy	Maintained	$200.00	+32.6%	07/06/2026
Puneet Souda Leerink Partners	Buy	Reiterated	-	-	06/02/2026
Paige Chamberlain‏ Wolfe Research	Buy	Reiterated	$150.00	-0.6%	06/01/2026
Unknown Analyst Wolfe Research	Buy	Reiterated	$150.00	-0.6%	06/01/2026
Andrew Brackmann William Blair	Buy	Maintained	-	-	05/27/2026
Andrew Cooper Raymond James	Buy	Reiterated	$129.00	-14.5%	02/23/2026

Lahat ng value sa USD	Set 2025	Dis 2025	Mar 2026	Hun 2026
Kita	265.20M	281.27M	301.66M	334.98M
Gastusin sa mga naibentang produkto	93.59M	99.49M	104.92M	115.95M
Halaga ng kita	93.59M	99.49M	104.92M	115.95M
Mga gastos sa pananaliksik at pag-develop	89.96M	98.26M	91.04M	96.53M
Kabuuang gastos sa pananaliksik at pag-develop	-	-	-	-
Mga gastos sa pagbebenta, pangkalahatan, at admin	180.53M	204.20M	227.06M	250.61M
Gastos sa pagpapatakbo	270.48M	302.46M	318.10M	347.15M
Kabuuang gastos sa pagpapatakbo	364.07M	401.96M	423.02M	463.10M
Kita sa pagpapatakbo	-98.87M	-120.69M	-121.35M	-128.12M
Iba pang hindi kita sa pagpapatakbo	-48.00K	-4.69M	1.55M	308.00K
EBT na may mga hindi karaniwang item	-92.59M	-130.22M	-111.70M	-119.96M
EBT na hindi kasama ang mga hindi karaniwang item	-92.47M	-116.52M	-111.70M	-118.96M
Gastos sa buwis sa kita	136.00K	-1.73M	372.00K	185.00K
Epektibong rate ng buwis	-0.15%	1.33%	-0.33%	-0.15%
Iba pang gastos sa pagpapatakbo	-	-	-	-
Net na kita	-92.72M	-128.49M	-112.08M	-120.14M
Margin ng kabuuang kita	-34.96%	-45.68%	-37.15%	-35.87%
Kita bawat share	-0.39	-0.50	-0.45	-0.42
Kita sa interes at investment	7.39M	10.03M	11.15M	10.20M
Gastos sa interes	-943.00K	-1.18M	-3.05M	-1.35M
Mga net na gastos sa interes	6.45M	8.85M	8.10M	8.85M
Mga singil sa depreciation at amortization	-	-	-	-
EBITDA	-89.47M	-110.64M	-111.91M	-118.56M
Kita o pagkalugi mula sa pagbebenta ng mga asset	-	-	-	-

Finance

Magtanong ng kahit na ano